The effects of magnetic field intensity, roasting temperature and roasting time on digestion rate and settling performance of bauxite with different iron contents were investigated systematically. The results indicate...The effects of magnetic field intensity, roasting temperature and roasting time on digestion rate and settling performance of bauxite with different iron contents were investigated systematically. The results indicate that such magnetic treatment can profoundly change the microstructure and digestion performance of bauxite. For the two samples carrying different iron contents, phase transformation of the aluminum oxide phase proceeds faster in the high iron bauxite than the low one. The optimal pretreatment conditions of low iron bauxite are roasting temperature 550 ℃ and magnetic field intensity 6 T, while for high iron bauxite are 500 ℃ and 9 T. The digestion rate of alumina can reach 95% and 92% at digestion temperature of 190 ℃ and 250 ℃. The settling performances of roasted ore by intense magnetic field after digestion are enhanced through pretreatment.展开更多
stem cell transplantation （allo-SCT） is a potential cure for patients with malignant lymphoma that is based on the graft-versus-lymphoma （GVL） effect. Myeloablative conditioning allo-SCT is associated with high mo...stem cell transplantation （allo-SCT） is a potential cure for patients with malignant lymphoma that is based on the graft-versus-lymphoma （GVL） effect. Myeloablative conditioning allo-SCT is associated with high mortality and morbidity, particularly in patients older than 45 years, heavily pretreated patients （prior hematopoietic stem cell transplantation or more than two lines of conventional chemotherapy） or patients affected by other comorbidities. Therefore, conventional allo-SCT is restricted to younger patients （〈50 to 55 years） in good physical condition. Over the last decade, allo-SCT with reduced-intensity conditioning （RIC-allo-SCT） has been increasingly used to treat patients with lymphoma. This treatment is associated with lower toxicity and substantial decrease in the incidence of transplant- related mortality, and has the potential to lead to long-term remissions. Therefore, patients who are not suitable to undergo conventional allo-SCT can benefit from the potentially curative GVL effects of allo-SCT. Although RIC-allo-SCT has improved the survival of lymphoma patients, high post-transplant relapse rates or disease progression mainly results in treatment failure. Thus, further improvement is clearly needed. The role and timing of RIC-allo-SCT in the treatment of lymphoma remains unclear. Therefore, more prospective studies should clarify the effectiveness of this method. In this article, we review the recent literature on RIC-alIo-SCT as a treatment for major lymphoma subtypes. Areas that require further investigation in the context of clinical trials are also highlighted.展开更多
基金Projects(U1202274,51004033,51204040,50974035)supported by the National Natural Science Foundation of ChinaProjects(2010AA03A405,2012AA062303)supported by the National High Technology Research and Development Program(863 Prograam)of ChinaProject(N100302005)supported by the Fundamental Research Funds for the Central Universities,China
文摘The effects of magnetic field intensity, roasting temperature and roasting time on digestion rate and settling performance of bauxite with different iron contents were investigated systematically. The results indicate that such magnetic treatment can profoundly change the microstructure and digestion performance of bauxite. For the two samples carrying different iron contents, phase transformation of the aluminum oxide phase proceeds faster in the high iron bauxite than the low one. The optimal pretreatment conditions of low iron bauxite are roasting temperature 550 ℃ and magnetic field intensity 6 T, while for high iron bauxite are 500 ℃ and 9 T. The digestion rate of alumina can reach 95% and 92% at digestion temperature of 190 ℃ and 250 ℃. The settling performances of roasted ore by intense magnetic field after digestion are enhanced through pretreatment.
文摘stem cell transplantation （allo-SCT） is a potential cure for patients with malignant lymphoma that is based on the graft-versus-lymphoma （GVL） effect. Myeloablative conditioning allo-SCT is associated with high mortality and morbidity, particularly in patients older than 45 years, heavily pretreated patients （prior hematopoietic stem cell transplantation or more than two lines of conventional chemotherapy） or patients affected by other comorbidities. Therefore, conventional allo-SCT is restricted to younger patients （〈50 to 55 years） in good physical condition. Over the last decade, allo-SCT with reduced-intensity conditioning （RIC-allo-SCT） has been increasingly used to treat patients with lymphoma. This treatment is associated with lower toxicity and substantial decrease in the incidence of transplant- related mortality, and has the potential to lead to long-term remissions. Therefore, patients who are not suitable to undergo conventional allo-SCT can benefit from the potentially curative GVL effects of allo-SCT. Although RIC-allo-SCT has improved the survival of lymphoma patients, high post-transplant relapse rates or disease progression mainly results in treatment failure. Thus, further improvement is clearly needed. The role and timing of RIC-allo-SCT in the treatment of lymphoma remains unclear. Therefore, more prospective studies should clarify the effectiveness of this method. In this article, we review the recent literature on RIC-alIo-SCT as a treatment for major lymphoma subtypes. Areas that require further investigation in the context of clinical trials are also highlighted.
